LncBase Experimental v.2
Help
Download
Please cite:
Maria D. Paraskevopoulou, Ioannis S. Vlachos, Dimitra Karagkouni, Georgios Georgakilas, Ilias Kanellos, Thanasis Vergoulis, Konstantinos Zagganas, Panayiotis Tsanakas, Evangelos Floros, Theodore Dalamagas, and Artemis G. Hatzigeorgiou "DIANA-LncBase v2: indexing microRNA targets on non-coding transcripts" Nucl. Acids Res. (2016) gkv1270
Bulk download:
We have updated the bulk download module, which simplifies the download process! Please find the new online form by following this link
Deprecated!
This version is deprecated. Users are strongly advised to only use the latest, up-to-date versions of DIANA-Tools and Databases.
Please follow this link to navigate to the latest database version.

hsa-miR-767-5p


or   Search by location
Loading... Please wait, this might take a few seconds...



Go to Predicted module
Filters
Gene
miRNA
Pr. score
DIANA Links
Methods
BLOC1S5-TXNDC5
hsa-miR-767-5p
-
mTTBlnPmP
IP

Gene Details
Chromosome: 6
Transcript: NR_037616.1
Biotype: sense
Gene id: NR_037616.1 (gene)
Gene Name: BLOC1S5-TXNDC5
UCSC graphic: -
Expression:
  Cell Line Tissue Category
K562 Blood Cancer/Malignant
HepG2 Liver Cancer/Malignant
A549 Lung Cancer/Malignant
MCF7 Mammary Gland Cancer/Malignant
LCLBACD1 - Normal/Primary

miRNA Details
Name: hsa-miR-767-5p
Sequence: ugcaccaugguugucugagcaug
MirBase ID: MIMAT0003882
Related Diseases:

Publication
Tissue
Cell Type
Methods
Xue Y et al. 2013
Cervix
HELA
IP
Tested Cell Line: HELA
Category: Cancer/Malignant
Experimental Condition: Hela cells were treated with control shRN.
Location
Region
Method
Result
Validation Type
Source
6:7882651-7882679
exon
HITS-CLIP
DIRECT
LncBasev2
CTB-89H12.4
hsa-miR-767-5p
0.430
mTTBlnPmP
IP

Gene Details
Chromosome: 5
Transcript: ENST00000499521
Biotype: retained_intron
Gene id: ENSG00000230551
Gene Name: CTB-89H12.4
UCSC graphic:
Expression:
  Cell Line Tissue Category
K562 Blood Cancer/Malignant
GM12878 Blood Cancer/Malignant
HUVEC Blood Vessel Normal/Primary
hMSC-BM Bone Marrow Stem/Progenitor
SK-N-SH Brain Cancer/Malignant
HeLa Cervix Cancer/Malignant
h1ESC Embryonic Stem Cells Embryonic/Fetal/Stem/Progenitor
HREpiC Kidney Normal/Primary
HepG2 Liver Cancer/Malignant
A549 Lung Cancer/Malignant
IMR90 Lung Embryonic/Fetal/Stem/Progenitor
MCF7 Mammary Gland Cancer/Malignant
LCLBAC - Normal/Primary
LCLBACD2 - Normal/Primary
LCLBACD1 - Normal/Primary
LCLBACD3 - Normal/Primary

miRNA Details
Name: hsa-miR-767-5p
Sequence: ugcaccaugguugucugagcaug
MirBase ID: MIMAT0003882
Related Diseases:

Publication
Tissue
Cell Type
Methods
Xue Y et al. 2013
Cervix
HELA
IP
Tested Cell Line: HELA
Category: Cancer/Malignant
Experimental Condition: Hela cells were treated with control shRN.
Location
Region
Method
Result
Validation Type
Source
5:149494435-149494463
exon
HITS-CLIP
DIRECT
LncBasev2
ENO1P1
hsa-miR-767-5p
-
mTTBlnPmP
IP

Gene Details
Chromosome: 1
Transcript: ENST00000366587
Biotype: transcribed_processed_pseudogene
Gene id: ENSG00000244457
Gene Name: ENO1P1
UCSC graphic:
Expression:
  Cell Line Tissue Category
A549 Lung Cancer/Malignant
LCLBACD1 - Normal/Primary
LCLBACD2 - Normal/Primary
LCLBAC - Normal/Primary
LCLBACD3 - Normal/Primary

miRNA Details
Name: hsa-miR-767-5p
Sequence: ugcaccaugguugucugagcaug
MirBase ID: MIMAT0003882
Related Diseases:

Publication
Tissue
Cell Type
Methods
Xue Y et al. 2013
Cervix
HELA
IP
Tested Cell Line: HELA
Category: Cancer/Malignant
Experimental Condition: Hela cells were treated with control shRNA.
Location
Region
Method
Result
Validation Type
Source
1:236483253-236483281
exon
HITS-CLIP
DIRECT
LncBasev2
NEAT1
hsa-miR-767-5p
0.855
mTTBlnPmP
IP

Gene Details
Chromosome: 11
Transcript: ENST00000501122
Biotype: lincRNA
Gene id: ENSG00000245532
Gene Name: NEAT1
UCSC graphic:
Expression:
  Cell Line Tissue Category
K562 Blood Cancer/Malignant
GM12878 Blood Cancer/Malignant
HUVEC Blood Vessel Normal/Primary
hMSC-BM Bone Marrow Stem/Progenitor
SK-N-SH Brain Cancer/Malignant
HeLa Cervix Cancer/Malignant
h1ESC Embryonic Stem Cells Embryonic/Fetal/Stem/Progenitor
HREpiC Kidney Normal/Primary
HepG2 Liver Cancer/Malignant
IMR90 Lung Embryonic/Fetal/Stem/Progenitor
A549 Lung Cancer/Malignant
MCF7 Mammary Gland Cancer/Malignant
HMEpC Mammary Gland Normal/Primary
LCLBACD1 - Normal/Primary
LCLBAC - Normal/Primary
LCLBACD2 - Normal/Primary
LCLBACD3 - Normal/Primary

miRNA Details
Name: hsa-miR-767-5p
Sequence: ugcaccaugguugucugagcaug
MirBase ID: MIMAT0003882
Related Diseases:

Publication
Tissue
Cell Type
Methods
Xue Y et al. 2013
Cervix
HELA
IP
Tested Cell Line: HELA
Category: Cancer/Malignant
Experimental Condition: Hela cells were treated with control shRN.
Location
Region
Method
Result
Validation Type
Source
11:65438816-65438844
exon
HITS-CLIP
DIRECT
LncBasev2
RP11-145M9.4
hsa-miR-767-5p
0.561
mTTBlnPmP
IP

Gene Details
Chromosome: 3
Transcript: ENST00000595265
Biotype: lincRNA
Gene id: ENSG00000269728
Gene Name: RP11-145M9.4
UCSC graphic:
Expression:
  Cell Line Tissue Category
K562 Blood Cancer/Malignant
HUVEC Blood Vessel Normal/Primary
hMSC-BM Bone Marrow Stem/Progenitor
SK-N-SH Brain Cancer/Malignant
HeLa Cervix Cancer/Malignant
h1ESC Embryonic Stem Cells Embryonic/Fetal/Stem/Progenitor
HREpiC Kidney Normal/Primary
A549 Lung Cancer/Malignant
IMR90 Lung Embryonic/Fetal/Stem/Progenitor
HMEpC Mammary Gland Normal/Primary
MCF7 Mammary Gland Cancer/Malignant
LCLBACD1 - Normal/Primary
LCLBACD3 - Normal/Primary
LCLBAC - Normal/Primary

miRNA Details
Name: hsa-miR-767-5p
Sequence: ugcaccaugguugucugagcaug
MirBase ID: MIMAT0003882
Related Diseases:

Publication
Tissue
Cell Type
Methods
Xue Y et al. 2013
Cervix
HELA
IP
Tested Cell Line: HELA
Category: Cancer/Malignant
Experimental Condition: Hela cells were treated with control shRN.
Location
Region
Method
Result
Validation Type
Source
3:179396476-179396504
exon
HITS-CLIP
DIRECT
LncBasev2
RP11-314B1.2
hsa-miR-767-5p
0.486
mTTBlnPmP
IP

Gene Details
Chromosome: 2
Transcript: ENST00000609089
Biotype: lincRNA
Gene id: ENSG00000273301
Gene Name: RP11-314B1.2
UCSC graphic:
Expression:
  Cell Line Tissue Category
HeLa Cervix Cancer/Malignant

miRNA Details
Name: hsa-miR-767-5p
Sequence: ugcaccaugguugucugagcaug
MirBase ID: MIMAT0003882
Related Diseases:

Publication
Tissue
Cell Type
Methods
Xue Y et al. 2013
Cervix
HELA
IP
Tested Cell Line: HELA
Category: Cancer/Malignant
Experimental Condition: Hela cells were treated with control shRN.
Location
Region
Method
Result
Validation Type
Source
2:225698996-225699024
exon
HITS-CLIP
DIRECT
LncBasev2
RP11-475C16.1
hsa-miR-767-5p
-
mTTBlnPmP
IP

Gene Details
Chromosome: 6
Transcript: ENST00000492974
Biotype: processed_pseudogene
Gene id: ENSG00000218426
Gene Name: RP11-475C16.1
UCSC graphic:
Expression: -

miRNA Details
Name: hsa-miR-767-5p
Sequence: ugcaccaugguugucugagcaug
MirBase ID: MIMAT0003882
Related Diseases:

Publication
Tissue
Cell Type
Methods
Xue Y et al. 2013
Cervix
HELA
IP
Tested Cell Line: HELA
Category: Cancer/Malignant
Experimental Condition: Hela cells were treated with control shRNA.
Location
Region
Method
Result
Validation Type
Source
6:153282420-153282448
exon
HITS-CLIP
DIRECT
LncBasev2
UBA52P5
hsa-miR-767-5p
-
mTTBlnPmP
IP

Gene Details
Chromosome: 8
Transcript: ENST00000461723
Biotype: processed_pseudogene
Gene id: ENSG00000243498
Gene Name: UBA52P5
UCSC graphic:
Expression:
  Cell Line Tissue Category
A549 Lung Cancer/Malignant

miRNA Details
Name: hsa-miR-767-5p
Sequence: ugcaccaugguugucugagcaug
MirBase ID: MIMAT0003882
Related Diseases:

Publication
Tissue
Cell Type
Methods
Xue Y et al. 2013
Cervix
HELA
IP
Tested Cell Line: HELA
Category: Cancer/Malignant
Experimental Condition: Hela cells were treated with control shRNA.
Location
Region
Method
Result
Validation Type
Source
8:123237017-123237045
exon
HITS-CLIP
DIRECT
LncBasev2
UBA52P7
hsa-miR-767-5p
-
mTTBlnPmP
IP

Gene Details
Chromosome: 12
Transcript: ENST00000486088
Biotype: processed_pseudogene
Gene id: ENSG00000241656
Gene Name: UBA52P7
UCSC graphic:
Expression: -

miRNA Details
Name: hsa-miR-767-5p
Sequence: ugcaccaugguugucugagcaug
MirBase ID: MIMAT0003882
Related Diseases:

Publication
Tissue
Cell Type
Methods
Xue Y et al. 2013
Cervix
HELA
IP
Tested Cell Line: HELA
Category: Cancer/Malignant
Experimental Condition: Hela cells were treated with control shRNA.
Location
Region
Method
Result
Validation Type
Source
12:115592772-115592800
exon
HITS-CLIP
DIRECT
LncBasev2
Funded by:
We have placed cookies on your device to help make this website and the services we offer better. By using this site, you agree to the use of cookies. Learn more
I accept